Zealand Pharma
565,5
DKK
+0,98 %
Mindre end 1K følgere
ZEAL
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
+0,98%
-20,13%
-20,96%
-21,46%
-35,45%
-21,35%
+516,68%
+197,95%
+611,32%
Zealand Pharma er aktiv inden for bioteknologi. Særligt fokus findes på udviklingen af lægemidler til behandling af diabetes og forskellige tarmsygdomme. Virksomheden har en varieret produktportefølje med separate mærker, der sælges på globalt plan. Den største forretning er på det nordiske marked. Zealand Pharma blev grundlagt i 1997 og har hovedkontor i Søborg.
Læs mereMarkedsværdi
40,18 mia. DKK
Aktieomsætning
140,93 mio. DKK
Omsætning
62,69 mio.
EBIT %
-2.029,37 %
P/E
-
Udbytteafkast, %
-
Finanskalender
27.3
2025
Generalforsamling '25
8.5
2025
Delårsrapport Q1'25
14.8
2025
Delårsrapport Q2'25
Alle
Analyse
Selskabsmeddelelser
ViserAlle indholdstyper
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity
Zealand Pharma convenes its Annual General Meeting 2025
Correction: Zealand Pharma Announces Financial Results for the Full Year 2024
Zealand Pharma Announces Financial Results for the Full Year 2024
Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th
